Clinical Trial Update: SYS6090 Combination Therapy in Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SYS6090 combination therapy in advanced lung cancer, covering Phase 1 and Phase 2 studies; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• SYS6090 (SYS6090)

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING